<DOC>
	<DOCNO>NCT01732250</DOCNO>
	<brief_summary>The purpose study determine whether addition meropenem colistin well colistin alone treatment clinically significant infection cause multi-drug resistant bacteria</brief_summary>
	<brief_title>Multicenter Open-label Randomized Controlled Trial ( RCT ) Compare Colistin Alone Versus Colistin Plus Meropenem</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Negative Bacterial Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>Adult inpatient Clinically significant , microbiologicaldocumented infection cause carbapenemresistant colistinsusceptible Gramnegative bacteria identify accord CDC criterion blood stream infection , hospital acquire pneumonia , ventilator associate pneumonia , urinary tract infection Patient recruitment occur microbiological documentation susceptibility test . Patients include within 96 hour time index culture take ( typically within 48 hour isolate identification ) , regardless antibiotic treatment administer time period . Previous inclusion trial . Patients include RCT first identify episode infection Pregnant woman Epilepsy prior seizure Known allergy colistin carbapenem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gram-Negative Bacterial Infections</keyword>
	<keyword>Resistant Bacteria</keyword>
	<keyword>Drug Resistance , Bacterial</keyword>
	<keyword>Colistin</keyword>
</DOC>